...
mist-img

Milestone Pharmaceuticals Inc, Common Stock

MIST

NSQ

$1.86

+$0.01

(0.54%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$98.66M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
289.21K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.73
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.12 L
$2.98 H
$1.86

About Milestone Pharmaceuticals Inc, Common Stock

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans, as well as with the Montreal Heart Institute, the WCN network, and other research centers. The company was incorporated in 2003 and is headquartered in Montréal, Canada. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameMISTSectorS&P500
1-Week Return-6.53%-2.12%0.77%
1-Month Return3.91%-2.54%2.65%
3-Month Return27.4%-6.28%12.3%
6-Month Return25.68%-1.36%13.48%
1-Year Return-41.88%9.29%33.47%
3-Year Return-67.02%10.05%32.22%
5-Year Return-88.89%43.69%92.85%
10-Year Return-87.9%103.1%194.31%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-15.00M15.00M5.00M1.00M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":33.33,"profit":true},{"date":"2023-12-31","value":6.67,"profit":true}]
Cost of Revenue236.00K376.00K-480.00K598.00K[{"date":"2019-12-31","value":39.46,"profit":true},{"date":"2020-12-31","value":62.88,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":80.27,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit(236.00K)(376.00K)15.00M5.00M1.00M[{"date":"2019-12-31","value":-1.57,"profit":false},{"date":"2020-12-31","value":-2.51,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":33.33,"profit":true},{"date":"2023-12-31","value":6.67,"profit":true}]
Gross Margin(Infinity%)(2.51%)100.00%100.00%100.00%[{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":-2.51,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses57.88M50.71M58.07M64.64M62.10M[{"date":"2019-12-31","value":89.54,"profit":true},{"date":"2020-12-31","value":78.45,"profit":true},{"date":"2021-12-31","value":89.84,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":96.06,"profit":true}]
Operating Income(57.88M)(50.71M)(43.07M)(59.64M)(61.10M)[{"date":"2019-12-31","value":-5788100000,"profit":false},{"date":"2020-12-31","value":-5071000000,"profit":false},{"date":"2021-12-31","value":-4307300000,"profit":false},{"date":"2022-12-31","value":-5964200000,"profit":false},{"date":"2023-12-31","value":-6109800000,"profit":false}]
Total Non-Operating Income/Expense5.19M1.45M440.00K2.51M3.22M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":27.97,"profit":true},{"date":"2021-12-31","value":8.47,"profit":true},{"date":"2022-12-31","value":48.31,"profit":true},{"date":"2023-12-31","value":62,"profit":true}]
Pre-Tax Income(55.28M)(49.98M)(42.85M)(58.39M)(59.69M)[{"date":"2019-12-31","value":-5528500000,"profit":false},{"date":"2020-12-31","value":-4998400000,"profit":false},{"date":"2021-12-31","value":-4285300000,"profit":false},{"date":"2022-12-31","value":-5838800000,"profit":false},{"date":"2023-12-31","value":-5968500000,"profit":false}]
Income Taxes(56.00K)(17.00K)(220.00K)(1.25M)(312.00K)[{"date":"2019-12-31","value":-5600000,"profit":false},{"date":"2020-12-31","value":-1700000,"profit":false},{"date":"2021-12-31","value":-22000000,"profit":false},{"date":"2022-12-31","value":-125400000,"profit":false},{"date":"2023-12-31","value":-31200000,"profit":false}]
Income After Taxes(55.23M)(49.97M)(42.63M)(57.13M)(59.37M)[{"date":"2019-12-31","value":-5522900000,"profit":false},{"date":"2020-12-31","value":-4996700000,"profit":false},{"date":"2021-12-31","value":-4263300000,"profit":false},{"date":"2022-12-31","value":-5713400000,"profit":false},{"date":"2023-12-31","value":-5937300000,"profit":false}]
Income From Continuous Operations(55.23M)(49.97M)(42.85M)(58.39M)(59.25M)[{"date":"2019-12-31","value":-5522900000,"profit":false},{"date":"2020-12-31","value":-4996700000,"profit":false},{"date":"2021-12-31","value":-4285300000,"profit":false},{"date":"2022-12-31","value":-5838800000,"profit":false},{"date":"2023-12-31","value":-5925100000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(55.23M)(49.97M)(42.63M)(57.13M)(59.69M)[{"date":"2019-12-31","value":-5522900000,"profit":false},{"date":"2020-12-31","value":-4996700000,"profit":false},{"date":"2021-12-31","value":-4263300000,"profit":false},{"date":"2022-12-31","value":-5713400000,"profit":false},{"date":"2023-12-31","value":-5968500000,"profit":false}]
EPS (Diluted)(2.60)(1.73)(1.02)(1.37)(1.39)[{"date":"2019-12-31","value":-260,"profit":false},{"date":"2020-12-31","value":-173,"profit":false},{"date":"2021-12-31","value":-102,"profit":false},{"date":"2022-12-31","value":-137,"profit":false},{"date":"2023-12-31","value":-139,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

MIST
Cash Ratio 14.53
Current Ratio 15.40

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

MIST
ROA (LTM) -33.09%
ROE (LTM) -133.75%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

MIST
Debt Ratio Lower is generally better. Negative is bad. 0.71
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.29

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

MIST
Trailing PE NM
Forward PE NM
P/S (TTM) 91.95
P/B 4.13
Price/FCF NM
EV/R 81.44
EV/Ebitda NM

FAQs

What is Milestone Pharmaceuticals Inc share price today?

Milestone Pharmaceuticals Inc (MIST) share price today is $1.86

Can Indians buy Milestone Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Milestone Pharmaceuticals Inc (MIST) on Vested. To buy Milestone Pharmaceuticals Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MIST stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Milestone Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Milestone Pharmaceuticals Inc (MIST) via the Vested app. You can start investing in Milestone Pharmaceuticals Inc (MIST) with a minimum investment of $1.

How to invest in Milestone Pharmaceuticals Inc shares from India?

You can invest in shares of Milestone Pharmaceuticals Inc (MIST) via Vested in three simple steps:

  • Click on Sign Up or Invest in MIST stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Milestone Pharmaceuticals Inc shares
What is Milestone Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Milestone Pharmaceuticals Inc (MIST) is $2.98. The 52-week low price of Milestone Pharmaceuticals Inc (MIST) is $1.12.

What is Milestone Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Milestone Pharmaceuticals Inc (MIST) is

What is Milestone Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Milestone Pharmaceuticals Inc (MIST) is 4.13

What is Milestone Pharmaceuticals Inc dividend yield?

The dividend yield of Milestone Pharmaceuticals Inc (MIST) is 0.00%

What is the Market Cap of Milestone Pharmaceuticals Inc?

The market capitalization of Milestone Pharmaceuticals Inc (MIST) is $98.66M

What is Milestone Pharmaceuticals Inc’s stock symbol?

The stock symbol (or ticker) of Milestone Pharmaceuticals Inc is MIST

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top